Core Points - A class action has been filed against Alexandria Real Estate Equities, Inc. (ARE) on behalf of investors who acquired its securities between January 27, 2025, and October 27, 2025 [1] - The allegations include misleading statements regarding Alexandria's financial prospects, particularly concerning revenue and funds from operations (FFO) growth for fiscal year 2025 [2] - On October 27, 2025, Alexandria reported disappointing third-quarter financial results and reduced its FFO guidance for the full year, citing lower occupancy rates and a significant real estate impairment charge of $323.9 million [3] Company Overview - Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT) focused on life science real estate, including lab space and research facilities for tenants in the pharmaceutical, biotech, and agricultural technology sectors [1] - The company has been promoting its Long Island City (LIC) property as a key part of its Megacampus™ strategy, which has come under scrutiny due to recent allegations [2] Financial Performance - The company experienced a significant decline in stock price, dropping approximately 19% from $77.87 per share on October 27, 2025, to $62.94 per share on October 28, 2025, following the announcement of its financial results [3]